Literatur
-
1
Taylor Jr H C.
Malignant and semimalignant tumors of the ovary.
Surg Gynecol Obstet.
1929;
48
204-230
-
2
du Bois A, Ewald-Riegler N et al.
Borderline-Tumoren des Ovars – eine systematische Übersicht.
GebFra.
2009;
69
807-833
-
3 du Bois A, Burges A, Emons G et al. Interdisziplinäre S2 k-Leitlinie für die Diagnostik und Therapie maligner Ovarialtumoren 2007. In: Schmalfeldt B, Pfisterer J, Hrsg., Kommission Ovar der AGO e. V. München: W. Zuckschwerdt Verlag; 2007
-
4
Sherman M E, Mink P J, Curtis R et al.
Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Cancer.
2004;
100
1045-1052
-
5
Seidman J D, Kurman R J.
Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
Hum Pathol.
2000;
31
539-557
-
6
Cusido M, Balaguero L, Hernandez G et al.
Results of the national survey of borderline ovarian tumors in Spain.
Gynecol Oncol.
2007;
104
617-622
-
7
Longacre T A, McKenney J K, Tazelaar H D et al.
Ovarian tumors of low malignant potential (borderline tumors).
Am J Surg Pathol.
2005;
29
707-723
-
8
Morice P, Camatte S, Rey A et al.
Prognostic factors for patients with advanced stage serous borderline tumors of the ovary.
Ann Oncol.
2003;
14
592-598
-
9
Cadron I, Leunen K, Gorp van T et al.
Management of borderline neoplasms.
J Clin Oncol.
2007;
25
2928-2937
-
10
Morice P.
Borderline tumours of the ovary and fertility.
Eur J Cancer.
2006;
42
149-158
-
11
du Bois A, Rochon J, Pfisterer J et al.
Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review.
Gynecol Oncol.
2008;
112
422-436
-
12
Kurman R J, Trimble C L.
The behaviour of serous tumors of low malignant potential: are they ever malignant?.
Inter J Gynecol Pathol.
1993;
12
120-127
-
13
Bostwick D G, Tazelaar H D, Ballon S C et al.
Ovarian epithelial tumors of borderline malignancy.
Cancer.
1986;
58
2052-2065
-
14
De Iaco P, Ferrero A, Rosati F et al.
Behaviour of ovarian tumors of low malignant potential treated with conservative surgery.
Eur J Surg Oncol.
2009;
35
643-648
-
15
Romangnolo C, Gadducci A, Sartori E et al.
Management of borderline ovarian tumors: Results of an Italian multicenter study.
Gynecol Oncol.
2006;
101
255-260
-
16
Yokoyama Y, Moriya T, Takano T et al.
Clinical outcome and risk factors for recurrence in borderline ovarian tumours.
Br J Cancer.
2006;
94
1586-1591
-
17
Morris R T, Gershenson D M, Silva E G et al.
Outcome and reproductive function after conservative surgery for borderline ovarian tumors.
Obstet Gynecol.
2000;
95
541-547
-
18
Poncelet C, Fauvet R, Boccara J et al.
Recurrence after cystectomy for borderline ovarian tumors: Results of a French multicenter study.
Ann Surg Oncol.
2006;
13
565-571
-
19
Chang S-J, Ryu H-S, Chang K-H et al.
Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
Acta Obstet Gynecol.
2008;
87
478-481
-
20
Fortin A, Morice P, Thoury A et al.
Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study.
Fertil Steril.
2007;
87
591-596
-
21
Kaern J, Tropé C G, Abeler V M.
A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982.
Cancer.
1993;
71
1810-1820
-
22
Bristow R E, Gossett D R, Shook D R et al.
Micropapillary serous ovarian carcinoma: surgical management and clinical outcome.
Gynecol Oncol.
2002;
86
163-170
-
23
Gershenson D M, Silva E G, Levy L et al.
Ovarian serous borderline tumors with invasive peritoneal implants.
Cancer.
1998;
82
1096-1103
-
24
Park J-Y, Bae J, Lim M C et al.
Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety.
Int J Gynecol Oncol.
2008;
18
1202-1209
-
25
Obermair A, Hiebl S.
Laparoscopy in the treatment of ovarian tumours of low malignant potential.
Aust NZ J Obstet Gynaecol.
2007;
47
438-444
-
26
Havrilesky L J, Peterson B L, Dryden D K et al.
Predictors of clinical outcomes in the laparoscopic management of adnexal masses.
Obstet Gynecol.
2003;
102
243-251
-
27
Vergote I, De Brabanter J, Fyles A et al.
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.
Lancet.
2001;
375
176-182
-
28
Emerson R E, Wang M, Liu F et al.
Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Int J Gynecol Pathol.
2007;
26
387-394
-
29
Bouchardy C, Fernandez S, Merglen A et al.
Increased risk of second cancer among patients with ovarian borderline tumors.
Gynecol Oncol.
2008;
109
210-214
-
30
Fort M G, Pierce V K, Saigo P E et al.
Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential.
Gynecol Oncol.
1989;
32
269-272
Korrespondenzadresse
Dr. med. N. Ewald-Riegler
Klinik für Gynäkologie und Gynäkologische Onkologie HSK Dr. Horst Schmidt Klinik
Ludwig-Erhard-Straße 100
65199 Wiesbaden
Email: Dr. N.EwRi@googlemail.com
